• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过网络分析和生存分析鉴定脑低级别胶质瘤的纯度和预后相关基因特征。

Identification of purity and prognosis-related gene signature by network analysis and survival analysis in brain lower grade glioma.

机构信息

Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, P. R. China.

Xiangya School of Medicine, Central South University, Changsha, P. R. China.

出版信息

J Cell Mol Med. 2020 Oct;24(19):11607-11612. doi: 10.1111/jcmm.15805. Epub 2020 Aug 31.

DOI:10.1111/jcmm.15805
PMID:32869484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7576230/
Abstract

Tumour microenvironment of brain lower grade glioma (LGG) consists of non-tumour cells including stromal cells and immune cells mainly. These non-tumour cells dilute the purity of LGG and play pivotal roles in tumour growth and development, thereby affecting patient prognosis. Tumour purity is also associated with molecular subtypes of LGG. In this study, we discovered the most relevant module to purity by weighted gene co-expression network analysis (WGCNA) and afterwards performed consensus network analysis and survival analysis to filter 61 significant genes related to both purity and prognosis. In turn, we built a simplified model based on the calculation of purity score, and consensus measurement of purity estimation (CPE), with a satisfactory predictive performance by random forest regression. HLA-E, MSN, GNG-5, MYL12A, ITGB4, PDPN, AGTRAP, S100A4, PLSCR1, VAMP5 were selected as the most relevant genes correlating to both purity and prognosis. The risk score model based on the 10 genes could moderately predict patients' overall survival. These 10 genes, respectively, were positively correlated positively to immunosuppressive cells like macrophage M2, but negatively correlated to patient prognosis, which may explain partially the poor prognosis with low-purity group.

摘要

脑低级别胶质瘤 (LGG) 的肿瘤微环境主要由非肿瘤细胞组成,包括基质细胞和免疫细胞。这些非肿瘤细胞降低了 LGG 的纯度,并在肿瘤的生长和发展中发挥关键作用,从而影响患者的预后。肿瘤纯度也与 LGG 的分子亚型有关。在这项研究中,我们通过加权基因共表达网络分析 (WGCNA) 发现了与纯度最相关的模块,然后进行共识网络分析和生存分析,筛选出与纯度和预后均相关的 61 个显著基因。接着,我们基于纯度得分的计算和纯度估计的共识度量 (CPE) 构建了一个简化模型,通过随机森林回归得到了令人满意的预测性能。HLA-E、MSN、GNG-5、MYL12A、ITGB4、PDPN、AGTRAP、S100A4、PLSCR1 和 VAMP5 被选为与纯度和预后均相关的最相关基因。基于这 10 个基因的风险评分模型可以适度预测患者的总生存率。这 10 个基因分别与巨噬细胞 M2 等免疫抑制细胞呈正相关,但与患者预后呈负相关,这可能部分解释了低纯度组预后不良的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e1f/7576230/b0565bd66c4f/JCMM-24-11607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e1f/7576230/77a7627075d1/JCMM-24-11607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e1f/7576230/b0565bd66c4f/JCMM-24-11607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e1f/7576230/77a7627075d1/JCMM-24-11607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e1f/7576230/b0565bd66c4f/JCMM-24-11607-g002.jpg

相似文献

1
Identification of purity and prognosis-related gene signature by network analysis and survival analysis in brain lower grade glioma.通过网络分析和生存分析鉴定脑低级别胶质瘤的纯度和预后相关基因特征。
J Cell Mol Med. 2020 Oct;24(19):11607-11612. doi: 10.1111/jcmm.15805. Epub 2020 Aug 31.
2
Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.TYROBP 表达升高预示低级别胶质瘤患者预后不良和肿瘤免疫浸润程度高。
BMC Cancer. 2021 Jun 23;21(1):723. doi: 10.1186/s12885-021-08456-6.
3
A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.弥漫性低级别胶质瘤患者个体化预后评估和放疗指导的五个 miRNA 特征。
J Cell Mol Med. 2020 Jul;24(13):7504-7514. doi: 10.1111/jcmm.15377. Epub 2020 May 15.
4
Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.低级别胶质瘤中与缺氧相关的长链非编码 RNA 与预后和免疫微环境相关。
Front Immunol. 2021 Sep 30;12:731048. doi: 10.3389/fimmu.2021.731048. eCollection 2021.
5
Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.基于转录组数据干性指标的加权基因预后模块共表达网络分析鉴定脑胶质瘤肿瘤干细胞特征。
J Mol Neurosci. 2020 Oct;70(10):1512-1520. doi: 10.1007/s12031-020-01590-z. Epub 2020 May 26.
6
Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.低级别胶质瘤中动力蛋白激活复合物基因的预后价值研究。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211010143. doi: 10.1177/15330338211010143.
7
Stemness subtypes in lower-grade glioma with prognostic biomarkers, tumor microenvironment, and treatment response.低级别胶质瘤的干性亚型与预后生物标志物、肿瘤微环境和治疗反应。
Sci Rep. 2024 Jun 26;14(1):14758. doi: 10.1038/s41598-024-65717-7.
8
Identification of Critical mA RNA Methylation Regulators with Prognostic Value in Lower-Grade Glioma.低级别胶质瘤中具有预后价值的关键 mA RNA甲基化调控因子的鉴定
Biomed Res Int. 2021 Jun 8;2021:9959212. doi: 10.1155/2021/9959212. eCollection 2021.
9
Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.发现预测低级别胶质瘤患者生存的 5 种特征。
World Neurosurg. 2019 Jun;126:e765-e772. doi: 10.1016/j.wneu.2019.02.147. Epub 2019 Mar 7.
10
The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data.低级别胶质瘤中有前途的新型生物标志物和候选小分子药物:高通量数据的生物信息学分析证据。
J Cell Biochem. 2019 Sep;120(9):15106-15118. doi: 10.1002/jcb.28773. Epub 2019 Apr 24.

引用本文的文献

1
Identification of tumor-specific T cell signature predicting cancer immunotherapy response in bladder cancer by multi-omics analysis and experimental verification.通过多组学分析和实验验证鉴定预测膀胱癌癌症免疫治疗反应的肿瘤特异性T细胞特征
Cancer Cell Int. 2024 Jul 20;24(1):255. doi: 10.1186/s12935-024-03447-6.
2
ITGB4 upregulation is associated with progression of lower grade glioma.ITGB4 的上调与低级别胶质瘤的进展有关。
Sci Rep. 2024 Jan 3;14(1):421. doi: 10.1038/s41598-023-49801-y.
3
Construction and validation of a risk model based on the key SNARE proteins to predict the prognosis and immune microenvironment of gliomas.

本文引用的文献

1
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.弥漫性脑世界卫生组织分级 II/III 级神经胶质瘤的 DNA 甲基化、转录组和遗传拷贝数特征解析肿瘤异质性和发生。
Acta Neuropathol Commun. 2019 Apr 25;7(1):59. doi: 10.1186/s40478-019-0704-8.
2
Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.胶质瘤中的癌症干细胞和免疫抑制微环境。
Front Immunol. 2018 Dec 21;9:2924. doi: 10.3389/fimmu.2018.02924. eCollection 2018.
3
The promises of immunotherapy in gliomas.
基于关键SNARE蛋白构建和验证风险模型以预测胶质瘤的预后和免疫微环境
Front Mol Neurosci. 2023 Dec 5;16:1304224. doi: 10.3389/fnmol.2023.1304224. eCollection 2023.
4
miR-21-5p inhibits the growth of brain glioma cells through regulating the glycolysis mediated by PFKFB2.miR-21-5p 通过调节 PFKFB2 介导的糖酵解抑制脑胶质瘤细胞的生长。
Funct Integr Genomics. 2023 Oct 21;23(4):322. doi: 10.1007/s10142-023-01246-2.
5
Overexpression of RAB34 associates with tumor aggressiveness and immune infiltration in glioma.RAB34 的过表达与胶质瘤的肿瘤侵袭性和免疫浸润有关。
Biosci Rep. 2022 Oct 28;42(10). doi: 10.1042/BSR20212624.
6
Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer.血管紧张素II受体相关蛋白作为一种预测泛癌免疫治疗反应的预后和免疫基因的泛癌分析
Front Cell Dev Biol. 2022 Aug 19;10:913684. doi: 10.3389/fcell.2022.913684. eCollection 2022.
7
Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma.免疫浸润相关的MAN2B1是一种新型的胶质瘤预后生物标志物。
Front Oncol. 2022 Feb 2;12:842973. doi: 10.3389/fonc.2022.842973. eCollection 2022.
8
Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma.是一种与肝细胞癌免疫浸润相关的预后生物标志物。
Front Oncol. 2021 Sep 14;11:713017. doi: 10.3389/fonc.2021.713017. eCollection 2021.
9
Long Noncoding RNA OR7E156P/miR-143/HIF1A Axis Modulates the Malignant Behaviors of Glioma Cell and Tumor Growth in Mice.长链非编码RNA OR7E156P/miR-143/HIF1A轴调节胶质瘤细胞的恶性行为及小鼠肿瘤生长
Front Oncol. 2021 Aug 6;11:690213. doi: 10.3389/fonc.2021.690213. eCollection 2021.
10
Establishment of a nomogram with EMP3 for predicting clinical outcomes in patients with glioma: A bi-center study.建立一个包含 EMP3 的列线图模型,用于预测胶质母细胞瘤患者的临床结局:一项双中心研究。
CNS Neurosci Ther. 2021 Oct;27(10):1238-1250. doi: 10.1111/cns.13701. Epub 2021 Jul 16.
免疫疗法在神经胶质瘤中的应用前景。
Curr Opin Neurol. 2017 Dec;30(6):650-658. doi: 10.1097/WCO.0000000000000491.
4
Tumor Purity as an Underlying Key Factor in Glioma.肿瘤纯度是脑胶质瘤的一个潜在关键因素。
Clin Cancer Res. 2017 Oct 15;23(20):6279-6291. doi: 10.1158/1078-0432.CCR-16-2598. Epub 2017 Jul 28.
5
Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas.胶质瘤恶性进展中的全面 RNA-seq 转录组特征分析。
Sci Data. 2017 Mar 14;4:170024. doi: 10.1038/sdata.2017.24.
6
T Cell Exhaustion in Glioblastoma: Intricacies of Immune Checkpoints.胶质母细胞瘤中的 T 细胞耗竭:免疫检查点的复杂性。
Trends Immunol. 2017 Feb;38(2):104-115. doi: 10.1016/j.it.2016.11.005. Epub 2016 Dec 7.
7
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类:概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
8
Systematic pan-cancer analysis of tumour purity.肿瘤纯度的系统性泛癌分析。
Nat Commun. 2015 Dec 4;6:8971. doi: 10.1038/ncomms9971.
9
Robust enumeration of cell subsets from tissue expression profiles.从组织表达谱中可靠地枚举细胞亚群。
Nat Methods. 2015 May;12(5):453-7. doi: 10.1038/nmeth.3337. Epub 2015 Mar 30.
10
Tumor-associated macrophages: from mechanisms to therapy.肿瘤相关巨噬细胞:从机制到治疗
Immunity. 2014 Jul 17;41(1):49-61. doi: 10.1016/j.immuni.2014.06.010.